1
de Vries, T.A.C., Hemels, M.E.W., Cools, F., Crijns, H.J.G.M., Yperzeele, L., Vanacker, P., Blankoff, I., Lancellotti, P., Mairesse, G.H., de Veer, A., Arroyo, R.C., Catez, E., de Pauw, M., Vanassche, T., de Asmundis, C., Kirchhof, P., De Caterina, R., de Groot, J.R., ETNA-AF-Europe, P.r.i.n.c.i.p.a.l.
Veröffentlicht in: de Vries , T A C , Hemels , M E W , Cools , F , Crijns , H J G M , Yperzeele , L , Vanacker , P , Blankoff , I , Lancellotti , P , Mairesse , G H , de Veer , A , Arroyo , R C , Catez , E , de Pauw , M , Vanassche , T , de Asmundis , C , Kirchhof , P , De Caterina , R , de Groot , J R , ETNA-AF-Europe , P R I N C I P A L & ETNA-AF-Europe principal investigators from Belgium and the Netherlands 2021 , ' Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study ' , Netherlands Heart Journal , vol. 29 , no. 3 , pp. 158-167 . https://doi.org/10.1007/s12471-020-01518-7;
2021
Veröffentlicht in: de Vries , T A C , Hemels , M E W , Cools , F , Crijns , H J G M , Yperzeele , L , Vanacker , P , Blankoff , I , Lancellotti , P , Mairesse , G H , de Veer , A , Arroyo , R C , Catez , E , de Pauw , M , Vanassche , T , de Asmundis , C , Kirchhof , P , De Caterina , R , de Groot , J R , ETNA-AF-Europe , P R I N C I P A L & ETNA-AF-Europe principal investigators from Belgium and the Netherlands 2021 , ' Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study ' , Netherlands Heart Journal , vol. 29 , no. 3 , pp. 158-167 . https://doi.org/10.1007/s12471-020-01518-7;
2021